Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2017 1
2018 3
2019 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Results by year

Filters applied: . Clear all
Page 1
Systematic Literature Review of Machine Learning Algorithms Using Pretherapy Radiologic Imaging for Glioma Molecular Subtype Prediction.
Lost J, Verma T, Jekel L, von Reppert M, Tillmanns N, Merkaj S, Petersen GC, Bahar R, Gordem A, Haider MA, Subramanian H, Brim W, Ikuta I, Omuro A, Conte GM, Marquez-Nostra BV, Avesta A, Bousabarah K, Nabavizadeh A, Kazerooni AF, Aneja S, Bakas S, Lin M, Sabel M, Aboian M. Lost J, et al. Among authors: marquez nostra bv. AJNR Am J Neuroradiol. 2023 Oct;44(10):1126-1134. doi: 10.3174/ajnr.A8000. AJNR Am J Neuroradiol. 2023. PMID: 37770204
Imaging of HER2 with [89Zr]pertuzumab in Response to T-DM1 Therapy.
Massicano AVF, Lee S, Crenshaw BK, Aweda TA, El Sayed R, Super I, Bose R, Marquez-Nostra BV, Lapi SE. Massicano AVF, et al. Among authors: marquez nostra bv. Cancer Biother Radiopharm. 2019 May;34(4):209-217. doi: 10.1089/cbr.2018.2654. Epub 2019 Jan 24. Cancer Biother Radiopharm. 2019. PMID: 30676778 Free PMC article.
Targeting HER2 in Nuclear Medicine for Imaging and Therapy.
Massicano AVF, Marquez-Nostra BV, Lapi SE. Massicano AVF, et al. Among authors: marquez nostra bv. Mol Imaging. 2018 Jan-Dec;17:1536012117745386. doi: 10.1177/1536012117745386. Mol Imaging. 2018. PMID: 29357745 Free PMC article. Review.
Preclinical PET imaging of glycoprotein non-metastatic melanoma B in triple negative breast cancer: feasibility of an antibody-based companion diagnostic agent.
Marquez-Nostra BV, Lee S, Laforest R, Vitale L, Nie X, Hyrc K, Keler T, Hawthorne T, Hoog J, Li S, Dehdashti F, Ma CX, Lapi SE. Marquez-Nostra BV, et al. Oncotarget. 2017 Nov 1;8(61):104303-104314. doi: 10.18632/oncotarget.22228. eCollection 2017 Nov 28. Oncotarget. 2017. PMID: 29262642 Free PMC article.
[89Zr]Trastuzumab: Evaluation of Radiation Dosimetry, Safety, and Optimal Imaging Parameters in Women with HER2-Positive Breast Cancer.
Laforest R, Lapi SE, Oyama R, Bose R, Tabchy A, Marquez-Nostra BV, Burkemper J, Wright BD, Frye J, Frye S, Siegel BA, Dehdashti F. Laforest R, et al. Among authors: marquez nostra bv. Mol Imaging Biol. 2016 Dec;18(6):952-959. doi: 10.1007/s11307-016-0951-z. Mol Imaging Biol. 2016. PMID: 27146421 Free PMC article. Clinical Trial.